Interleukin-10 is a critical regulator of white matter lesion containment following viral induced demyelination

GLIA

Volumn 63, Issue 11, 2015, Pages 2106-2120

  Puntambekar, Shweta S ^a   Hinton, David R ^b   Yin, Xinghua ^a   Savarin, Carine ^a   Bergmann, Cornelia C ^a   Trapp, Bruce D ^a   Stohlman, Stephen A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Astrocyte; Demyelination; Interleukin 10; Microglia; Virus

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; MESSENGER RNA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL STRUCTURE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CORONAVIRIDAE INFECTION; DEMYELINATING DISEASE; HYPERTROPHY; INFECTION CONTROL; MACROPHAGE; MICROGLIA; MOUSE; MURINE HEPATITIS VIRUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; VIRAL CLEARANCE; VIRUS IMMUNITY; WHITE MATTER INJURY; WHITE MATTER LESION; WILD TYPE;

EID: 84941192905     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22880     Document Type: Article

References (69)

1. Anghelina D, Zhao J, Trandem K, Perlman S. 2009. Role of regulatory T cells in coronavirus-induced acute encephalitis. Virology 385:358-367.
2. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol 55:458-468.
3. Bender SJ, Weiss SR. 2010. Pathogenesis of murine coronavirus in the central nervous system. J Neuroimmune Pharmacol 5:336-354.
4. Bergmann CC, Altman JD, Hinton D, Stohlman SA. 1999. Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system. J Immunol 163:3379-3387.
5. Bergmann CC, Lane TE, Stohlman SA. 2006. Coronavirus infection of the central nervous system: Host-virus stand-off. Nat Rev Microbiol 4:121-132.
6. Bergmann CC, Parra B, Hinton DR, Ramakrishna C, Dowdell KC, Stohlman SA. 2004. Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J Virol 78:1739-1750.
7. Butler NS, Harris TH, Blader IJ. 2013. Regulation of immunopathogenesis during Plasmodium and Toxoplasma infections: More parallels than distinctions? Trends Parasitol 29:593-602.
8. Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, Greenberg N, Schwartz A, Smirnov I, Pollack A, Jung S, Schwartz M. 2006. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest 116:905-915.
9. Couper KN, Blount DG, Riley EM. 2008a. IL-10: the master regulator of immunity to infection. J Immunol 180:5771-5777.
10. Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, Kamanaka M, Flavell RA, de Souza JB, Riley EM. 2008b. IL-10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog 4:e1000004.
11. Cregg JM, DePaul MA, Filous AR, Lang BT, Tran A, Silver J. 2014. Functional regeneration beyond the glial scar. Exp Neurol 253:197-207.
12. Chen F, Liu Z, Wu W, Rozo C, Bowdridge S, Millman A, Van Rooijen N, Urban JF Jr, Wynn TA, Gause WC. 2012. An essential role for TH2-type responses in limiting acute tissue damage during experimental helminth infection. Nat Med 18:260-266.
13. de Aquino MT, Kapil P, Hinton DR, Phares TW, Puntambekar SS, Savarin C, Bergmann CC, Stohlman SA. 2014. IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination. J Immunol 193:285-294.
14. de Aquino MT, Puntambekar SS, Savarin C, Bergmann CC, Phares TW, Hinton DR, Stohlman SA. 2013. Role of CD25(+) CD4(+) T cells in acute and persistent coronavirus infection of the central nervous system. Virology 447:112-120.
15. Fahey LM, Brooks DG. 2010. Opposing positive and negative regulation of T cell activity during viral persistence. Curr Opin Immunol 22:348-354.
16. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. 2004. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24:2143-2155.
17. Fleming JO, Trousdale MD, el-Zaatari FA, Stohlman SA, Weiner LP. 1986. Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 58:869-875.
18. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol 154:4309-4321.
19. Fujinami RS, von Herrath MG, Christen U, Whitton JL. 2006. Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19:80-94.
20. Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, Korsak RA, Takeda K, Akira S, Sofroniew MV. 2008. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 28:7231-7243.
21. Holscher C, Mohrs M, Dai WJ, Kohler G, Ryffel B, Schaub GA, Mossmann H, Brombacher F. 2000. Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice. Infect Immun 68:4075-4083.
22. Hulshof S, Montagne L, De Groot CJ, Van Der Valk P. 2002. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia 38:24-35.
23. Kapil P, Atkinson R, Ramakrishna C, Cua DJ, Bergmann CC, Stohlman SA. 2009. Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control. J Virol 83:5978-5986.
24. Kapil P, Butchi NB, Stohlman SA, Bergmann CC. 2012. Oligodendroglia are limited in type I interferon induction and responsiveness in vivo. Glia 60:1555-1566.
25. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. 2009. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29:13435-13444.
26. Kulcsar KA, Baxter VK, Greene IP, Griffin DE. 2014. Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis. Proc Natl Acad Sci U S A 111:16053-16058.
27. Kullberg MC, Jankovic D, Gorelick PL, Caspar P, Letterio JJ, Cheever AW, Sher A. 2002. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 196:505-515.
28. Ledeboer A, Wierinckx A, Bol JG, Floris S, Renardel de Lavalette C, De Vries HE, van den Berg TK, Dijkstra CD, Tilders FJ, van dam AM. 2003. Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE. J Neuroimmunol 136:94-103.
29. Liedtke W, Edelmann W, Chiu FC, Kucherlapati R, Raine CS. 1998. Experimental autoimmune encephalomyelitis in mice lacking glial fibrillary acidic protein is characterized by a more severe clinical course and an infiltrative central nervous system lesion. Am J Pathol 152:251-259.
30. Lin MT, Hinton DR, Marten NW, Bergmann CC, Stohlman SA. 1999. Antibody prevents virus reactivation within the central nervous system. J Immunol 162:7358-7368.
31. Lin MT, Hinton DR, Parra B, Stohlman SA, van der Veen RC. 1998. The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. Virology 245:270-280.
32. Lund JM, Hsing L, Pham TT, Rudensky AY. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320:1220-1224.
33. Martinez-Pomares L. 2012. The mannose receptor. J Leuk Biol 92:1177-1186.
34. Metz L, Bell R, Zochodne D. 1994. Interferon beta treatment of multiple sclerosis. Neurology 44:187-188.
35. Miron VE, Boyd A, Zhao JW, Yuen TJ, Ruckh JM, Shadrach JL, van Wijngaarden P, Wagers AJ, Williams A, Franklin RJ, ffrench-Constant C. 2013. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16:1211-1218.
36. Molina-Holgado E, Vela JM, Arevalo-Martin A, Guaza C. 2001. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: Role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur J Neurosci 13:493-502.
37. Mosser DM, Edwards JP. 2008. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-969.
38. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, Okano H. 2006. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12:829-834.
39. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA. 1999. IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 162:1641-1647.
40. Phares TW, DiSano KD, Stohlman SA, Bergmann CC. 2014. Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis. J Virol 88:8853-8867.
41. Phares TW, Stohlman SA, Hinton DR, Atkinson R, Bergmann CC. 2010. Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis. J Immunol 185:5607-5618.
42. Pot C, Apetoh L, Kuchroo VK. 2011. Type 1 regulatory T cells (Tr1) in autoimmunity. Semin Immunol 23:202-208.
43. Puntambekar SS, Bergmann CC, Savarin C, Karp CL, Phares TW, Parra GI, Hinton DR, Stohlman SA. 2011. Shifting hierarchies of interleukin-10-producing T cell populations in the central nervous system during acute and persistent viral encephalomyelitis. J Virol 85:6702-6713.
44. Ramakrishna C, Bergmann CC, Atkinson R, Stohlman SA. 2003. Control of central nervous system viral persistence by neutralizing antibody. J Virol 77:4670-4678.
45. Ramakrishna C, Stohlman SA, Atkinson RD, Shlomchik MJ, Bergmann CC. 2002. Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J Immunol 168:1204-1211.
46. Richards MH, Getts MT, Podojil JR, Jin YH, Kim BS, Miller SD. 2011. Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS. J Autoimmun 36:142-154.
47. Saraiva M, O'Garra A. 2010. The regulation of IL-10 production by immune cells. Nat Rev Immunol 10:170-181.
48. Savarin C, Stohlman SA, Atkinson R, Ransohoff RM, Bergmann CC. 2010. Monocytes regulate T cell migration through the glia limitans during acute viral encephalitis. J Virol 84:4878-4888.
49. Savarin C, Stohlman SA, Hinton DR, Ransohoff RM, Cua DJ, Bergmann CC. 2012. IFN-gamma protects from lethal IL-17 mediated viral encephalomyelitis independent of neutrophils. J Neuroinflammation 9:104.
50. Schindler C, Levy DE, Decker T. 2007. JAK-STAT signaling: From interferons to cytokines. J Biol Chem 282:20059-20063.
51. Shirey KA, Pletneva LM, Puche AC, Keegan AD, Prince GA, Blanco JC, Vogel SN. 2010. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent. Mucosal Immunol 3:291-300.
52. Silver J, Miller JH. 2004. Regeneration beyond the glial scar. Nat Rev Neurosci 5:146-156.
53. Sofroniew MV, Vinters HV. 2010. Astrocytes: Biology and pathology. Acta Neuropathol 119:7-35.
54. Starossom SC, Mascanfroni ID, Imitola J, Cao L, Raddassi K, Hernandez SF, Bassil R, Croci DO, Cerliani JP, Delacour D, Wang Y, Elyaman W, Khoury SJ, Rabinovich GA. 2012. Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration. Immunity 37:249-263.
55. Stohlman SA, Hinton DR, Parra B, Atkinson R, Bergmann CC. 2008. CD4 T cells contribute to virus control and pathology following central nervous system infection with neurotropic mouse hepatitis virus. J Virol 82:2130-2139.
56. Sun J, Cardani A, Sharma AK, Laubach VE, Jack RS, Muller W, Braciale TJ. 2011. Autocrine regulation of pulmonary inflammation by effector T-cell derived IL-10 during infection with respiratory syncytial virus. PLoS Pathog 7:e1002173.
57. Sun J, Madan R, Karp CL, Braciale TJ. 2009. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 15:277-284.
58. Templeton SP, Kim TS, O'Malley K, Perlman S. 2008. Maturation and localization of macrophages and microglia during infection with a neurotropic murine coronavirus. Brain Pathol 18:40-51.
59. Toft-Hansen H, Fuchtbauer L, Owens T. 2011. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 59:166-176.
60. Trandem K, Anghelina D, Zhao J, Perlman S. 2010. Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus. J Immunol 184:4391-4400.
61. Trandem K, Zhao J, Fleming E, Perlman S. 2011. Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis. J Immunol 186:3642-3652.
62. Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S, Sofroniew MV. 2009. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 29:11511-11522.
63. Wang FI, Hinton DR, Gilmore W, Trousdale MD, Fleming JO. 1992. Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest 66:744-754.
64. Wanner IB, Anderson MA, Song B, Levine J, Fernandez A, Gray-Thompson Z, Ao Y, Sofroniew MV. 2013. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci 33:12870-12886.
65. Weiner HL, Selkoe DJ. 2002. Inflammation and therapeutic vaccination in CNS diseases. Nature 420:879-884.
66. Wu GF, Dandekar AA, Pewe L, Perlman S. 2000. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 165:2278-2286.
67. Xin J, Wainwright DA, Mesnard NA, Serpe CJ, Sanders VM Jones KJ. 2011. IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection. Brain Behav Immun 25:820-829.
68. Xue S, Sun N, Van Rooijen N, Perlman S. 1999. Depletion of blood-borne macrophages does not reduce demyelination in mice infected with a neurotropic coronavirus. J Virol 73:6327-6334.
69. Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, Wu PM, Doykan CE, Lin J, Cotleur AC, Kidd G, Zorlu MM, Sun N, Hu W, Liu L, Lee JC, Taylor SE, Uehlein L, Dixon D, Gu J, Floruta CM, Zhu M, Charo IF, Weiner HL, Ransohoff R. 2014. Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med 211:1533-1549.